Estrogenic and DNA-damaging activity of Red No. 3 in human breast cancer cells

Environmental Health Perspectives

Volumn 105, Issue SUPPL. 3, 1997, Pages 625-632

  Dees, Craig ^a,e   Askari, Minoo ^b   Garrett, Scott ^c   Gehrs, Kellie ^a   Henley, Don ^b   Ardies, C Murray ^d  

^a OAK RIDGE NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c OAK RIDGE INSTITUTE FOR SCIENCE AND EDUCATION   (United States)

^d NORTHEASTERN ILLINOIS UNIVERSITY   (United States)

^e PhotoGen LLC   (United States)

Author keywords

Breast cancer; DDT; p53; Red No. 3; Xenoestrogen

Indexed keywords

CYCLIN DEPENDENT KINASE; DYE; ERYTHROSINE; ESTROGEN; ESTROGEN RECEPTOR; PESTICIDE;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CELL GROWTH; CONFERENCE PAPER; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; ENZYME ACTIVITY; EPITHELIUM CELL; ESTROGEN ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LIVER CELL; PRIORITY JOURNAL; RISK FACTOR;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0030995499     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.97105s3625     Document Type: Conference Paper

References (43)

1. Anonymous. Morb Mortal Wkly Rep 41:454 (1992).
2. Marshall, E. Search for a killer: focus shifts from fat to hormones. Science 259:618-621 (1993).
3. Elixhauser A. Costs of breast cancer and the cost-effectiveness of breast cancer screening. Int J Technol Assess Health Care 7:604-615 (1991).
4. Pelehach L. Scientists isolate breast and ovarian cancer gene. Lab Med 25:11 (1994).
5. Harris JR, Lippman ME, Veronesi U, Willet W. Breast cancer. N Engl J Med 327:319-328 (1992).
6. Willet WC. What should we eat? Science 264:532-537 (1994).
7. Stone R. Environmental estrogens stir up debate. Science 265:308-310 (1994).
8. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anto-Culver H. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372-377 (1993).
9. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83:2496-2500 (1986).
10. Robison AK, Sirbasku DA, Stancel GM. DDT supports the growth of an estrogen-responsive tumor. Toxicol Lett 27:109-113.
11. 3H] estradiol to the rat uterine receptor. Chem Pharmacol 23:451-454 (1974).
12. Krieger N, Wolff MSA, Hiatt RA, Rivera M, Vogelman J, Orentreich N. Breast cancer and serum organochlorines - a prospective study among white, black, and Asian women. J Natl Cancer Inst 86:589-599 (1994).
13. Anderson LF. DDT and breast cancer: the verdict isn't in. J Natl Cancer Inst 86:76-77 (1994).
14. Desailly E, Dodin S, Verreault R, Ayotte P, Sauve L, Morin P, Brisson J. High organochlorine body burden in women with estrogen receptor positive breast cancer. J Natl Cancer Inst 86:232-234 (1994).
15. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP. A variety of environmentally persistent chenmicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect 103:582-586 (1995).
16. Dees C, Travis C. Increased p53 site-specific DNA binding in cells producing mutant p53. Cancer Lett 96:225 (1995).
17. Foster JS, Wimalasena J. Estrogen and antiestrogen regulate cyclin dependent kinase 2 (Cdk2) activity and retinoblastoma protein. Mol Endocrinol 10:488-498 (1996).
18. Kumar V, Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 55-145-156 (1988).
19. Tishler RB, Calderwood SK, Coleman CN, Price BD. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents. Cancer Res 53:2212-2216 (1993).
20. Price BD, Calderwood SK. Increased squence-specihc p53-DNA binding activity after DNA damage is attenuated by phorbol esters. Oncogene 8:3055-3062 (1993).
21. Pagano M, Pepperkok R, Lukas J, Baldwin V, Ansorge W, Bartek J, Draetta G. Regulation of the cell cycle by the Cdk2 protein kinase in cultured human fibroblasts. J Cell Biol 121:101-111 (1993).
22. Sherr CJ. Cycling on cue. Cell 79:551-555 (1993).
23. Akiyama T, Ohuchuy T, Sumida S, Matsumoto K, Toyoshima K. Phosphorylation of the retinoblastoma protein by Cdk2. Proc Natl Acad Sci USA 89:7900-7904 (1992).
24. Matsumoto H, Shimura M, Omatsu T, Okaichi K, Majima H, Ohnishi T. p53 proteins accumulated by heat stress associate with heat shock proteins HSP72/HSP73 in human glioblastoma cell lines. Cancer Lett 87:39-46 (1994).
25. Graebler TG, Peterson JF, Tasi M, Monica K, Ofnace AJ, Giaccia A. Hypoxia induces accumulation of p53 protein, but inactivation of G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 14:6264-6277 (1994)
26. Jayaraman L, Prives C. Activation of p53 sequence-specific DNA binding by short single strands of DNA requires the p53 C-terminus. Cell 81:1021-1029 (1995).
27. Lee S, Elenbass B, Levine A, Griffith J. p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81:1013-1020 (1995).
28. Lakdawalla AA, Netrawali MS. Eryrosine, a permitted food dye, is mutagenic in the Bacillus subtilus multigene sporulation assay. Mutat Res 202:171-176 (1988).
29. Lakdawalla AA, Netrawali MS. Mutagenicity, comutagenicity, and antimutagenicity of erythrosine (FD and C Red 3), a food dye, in the Ames/Salmonella assay. Mutat Res 204:131-139 (1988).
30. Hiasa Y, Ohsima M, Kitahori Y, Konishi N, Shimoyama T, Sakaguchi Y, Hashimoto H, Minami S, Kto Y. The promoting effects of food dyes, erythosine (Red 3) and rose bengal B (Red 105), on thyroid tumors in partially thryroidectomized N-bis(2-hydroxypropyl)-nitrosamine-treated rats. Jpn J Cancer Res 79:314-319 (1988).
31. Lippman M, Monaco ME, Dickson RB. Mechanisms of growth control in normal and malignant breast epithelium. Recent Prog Horm Res 45:383-440 (1989).
32. Travis CC, Arms AD. The food chain as a source of toxic chemical exposure. In: Toxic Chemicals, Health and the Environment (Lave LB, Upton A, eds). Baltimore, MD:Johns Hopkins University Press 1987;95-1213.
33. Mueller HR. The effect of industrial handling on micronutrients. J Nutr Sci Vitaminol (Tokyo) 36:47-55 (1990).
34. Thayer AM. Use of specialty food additives continues to grow. Chem Eng News 9-12 (June 3, 1991).
35. National Academy of Sciences/National Research Council. The 1977 Survey of Industry on the Use of Food Additives: Estimates of Daily Intake. Vol 3. Washington:National Academy Press, 1979.
36. Dees C, Askari M, Travis C, Foster JS, Wimalasena J. DDT stimulates human breast cancer cells to enter the cell cycle. Mol Carcinog 18:107-114 (1997).
37. Kato S, Endoh H, Masuhire Y, Kitamoto T, Uchiyama S, Saskai H, Masushige S, Gotoh, Nishida E, Kawashima H, et al. Activation of the estrogen-receptor through phosphorylation by mitogen-activated protein-kinase. Science 270:1491-1494 (1995).
38. Bunone G, Briand PA, Miksicek RJ, Picard D. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15:2174-2183 (1996).
39. Joel PB, Triash HM, Launigan DA. Estradiol and phorbol ester cause phosphorylation of serine 118 in the human estrogen receptor. Mol Endocrinol 9:1041-1052 (1995).
40. Arnold SF, Klotz DM, Collins BM, Vonier PM, Guillette LJ, McLachlan JA. Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 272:1489-1492 (1996).
41. Russo J, Gusterson BA, Rogers AE, Russo IH, Wellings SE, van Zwieten MJ. Biology of disease. Comparative study of human and rat mammary tumorigenesis. Lab Invest 62:244-278 (1990).
42. Hilakivi-Clarke I., Cho E, Raygada M, Clarke R. How early estrogenic activity affects mammary gland development to increase breast cancer risk. Proc 86th Annu Meet Am Assoc Cancer Res 36:261 (1995).
43. Nelson KG, Saki Y, Eitzman B, Steed T, McLachlan J. Exposure to diethylsilbesterol during a critical developmental period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes. Cell Growth Differ 5:595-606 (1994).